Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-3,906 Cr₹-77 Cr₹-520 Cr₹-442 Cr₹-445 Cr

What is the latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS is ₹-3,906 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-3,906 Cr
Mar2023₹-77 Cr
Mar2022₹-520 Cr
Mar2021₹-442 Cr
Mar2020₹-445 Cr

How is Cash Flow from Financing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-3,906 Cr
Negative
Mar2023 ₹-77 Cr
Negative
Mar2022 ₹-520 Cr
Negative
Mar2021 ₹-442 Cr
Negative
Mar2020 ₹-445 Cr -

Compare Cash Flow from Financing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,513.6 Cr -1.8% 23.9% 50.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.8%

23.9%

50.5%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses